Drug Quality and Security Act Awaiting to be Passed by Senate

The Drug Quality and Security Act is awaiting the decision of the Senate.  This bill was presented “to amend the Federal Food, Drug, and Cosmetic Act with respect to human drug compounding and drug supply chain security, and for other purposes.”

The bill was first introduced September 27th and was passed by the House on the 28th.

“We believe this bill helps clarify federal oversight of compounding outsourcing facilities, and seeks to create better communication channels between the Food and Drug Administration (FDA) and state boards of pharmacy. In the interest of patient safety we urge Congress to pass this legislation.” –American Society of Health-System Pharmacists

The bill would improve drug safety and help prevent a future public health crisis like the 2012 meningitis outbreak tied to the New England Compounding Center.

Our defective drug attorneys at the law firm of Zoll, Kranz & Borgess, LLC represent victims and the families of victims injured or killed as a result of defective drugs suffering from personal injury or wrongful death.  To learn more or to report a possible claim, call toll free (888)841-9623